Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Year | Description |
| 1997 | Invention patented by Thomas S. Arrhenius, Mariano J. Elices, and Federico C. Gaeta on September 2nd, 1997. Abstract: The present invention contemplates a peptide that inhibits the binding between the VLA-4 receptor expressed on inflammatory leukocytes and the fibronectin CS-1 peptide expressed on endothelial cells that are involved in immunoinflammatory disease states. Pharmaceutical compositions containing a contemplated peptide and processes for treating immunoinflammatory conditions using a binding-inhibitory peptide are also disclosed. |
| Source: selected by the editor from original sources. | |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
